COMPANIES COVERED
PfizerDownload FREE Report Sample
Download Free sampleNeuropathic pain is pain caused by damage or disease affecting the somatosensory nervous system. Neuropathic pain may be associated with abnormal sensations called dysesthesia or pain from normally non-painful stimuli (allodynia).
Neuropathic Pain Drugs Market contains market size and forecasts of Neuropathic Pain Drugs in Global, including the following market information:
Global Neuropathic Pain Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Neuropathic Pain Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tricyclic Anti-Depressants Anticonvulsants Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Neuropathic Pain Drugs include Pfizer, Johnson & Johnson, Sanofi, GlaxoSmithKline, Eli Lilly, Bristol-Myers Squibb, Biogen, Baxter Healthcare and Depomed. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Neuropathic Pain Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Neuropathic Pain Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Neuropathic Pain Drugs Market Segment Percentages, by Type, 2021 (%)
Tricyclic Anti-Depressants Anticonvulsants
Serotonin-Norepinephrine Reuptake Inhibitor
Capsaicin Cream
Local Anaesthesia
Opioids
Steroids
Others
Global Neuropathic Pain Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Neuropathic Pain Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Neuropathic Pain Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Neuropathic Pain Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Neuropathic Pain Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Neuropathic Pain Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Johnson & Johnson
Sanofi
GlaxoSmithKline
Eli Lilly
Bristol-Myers Squibb
Biogen
Baxter Healthcare
Depomed
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
